Skip to content
Home/Companies/Pharma/Skyepharma
Skyepharma

Skyepharma

Pharma·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Skyepharma?

Skyepharma is a French Pharma company, currently owned by Jadel since 2021.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Jadel
Investor
Jadel
Jadel Evergreen · 2021 · Evergreen

Key facts

HQFrance
SectorPharma
Websitewww.skyepharma.com

More from Jadel Evergreen

Other portfolio companies in the same fund.

Clavel Assurances
Active
France· 2026
CNS Communications
CNS Communications
Active
IT ServicesFrance· 2025
ATA Electronics
Active
IndustrialsFrance· 2024
Isore
Isore
Exited 2025
Real EstateFrance· 2023
to InnovaFonds and management
Reynaud & Fils
Reynaud & Fils
Active
ConsumerFrance· 2023
Ceetal
Active
Business ServicesFrance· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Skyepharma?

Skyepharma is currently owned by Jadel, through Jadel Evergreen, since 2021.

When did Jadel acquire Skyepharma?

Jadel acquired Skyepharma in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue